TABLE 3.
Cervical status | N | HPV, individual types
|
|||||
---|---|---|---|---|---|---|---|
Cyto | Histo | Complete agreement N (%) |
Partial agreement (extra types in cells) N (%) |
Partial agreement (extra types in biopsy) N (%) |
Partial agreement (extra types in both) N (%) |
All discordant N (%) |
|
Norm | Norm | 14 | 4 (28.6) | 6 (42.9) | 1 (7.1) | 0 (0.0) | 3 (21.4) |
Any | ≤CIN1b | 67 | 21 (31.3) | 31 (46.3) | 2 (3.0) | 7 (10.4) | 6 (9.0) |
<HSIL | CIN2/3 | 30 | 11 (36.7) | 13 (43.3) | 1 (3.3) | 2 (6.7) | 3 (10.0) |
HSIL | CIN2/3 | 50 | 19 (38.0) | 25 (50.0) | 2 (4.0) | 2 (4.0) | 2 (4.0) |
Overall | 161c | 55 (34.2) | 75 (46.6) | 6 (3.7) | 11 (6.8) | 14 (8.7) |
Only pairs in which both cells and biopsy were HPV-positive.
Including normal biopsies only in combination with any cytological abnormality.
6 women with uncharacterized HPV types are not included.
CIN: cervical intraepithelial neoplasia; HSIL: high-grade squamous intraepithelial lesion.